loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

List of Certificates of Suitability (CEPs) for r1_cep_2001_385___rev_08 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 HTL Javené FR (1)

filter

01 Sodium hyaluronate, Intrinsic viscosity: 1.7 m3/kg, 1.9 m3/kg, 2.4 m3/kg, 2.8 m3/kg, or 3.5 m3/kg, by fermentation, for parenteral administration including intra-articular use and intra-ocular use (1)

filter

01 France (1)

filter

01 Valid (1)

Looking for Certificates of Suitability (CEPs) for R1-CEP 2001-385 - Rev 08 of Htl Javené Fr

Looking for Certificates of Suitability (CEPs) for R1-CEP 2001-385 - Rev 08 of Htl Javené Fr 1

20

Htl Javené Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for HTL Biotechnology is the world leader in the responsible development and production of pharmaceutical-grade biopolymers.

One of their significant offerings is Sodium hyaluronate, Intrinsic viscosity: 1.7 m3/kg, 1.9 m3/kg, 2.4 m3/kg, 2.8 m3/kg, or 3.5 m3/kg, by fermentation, for parenteral administration including intra-articular use and intra-ocular use, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-385 - Rev 08

This Chemical Type CEP, issued on September 19, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1472 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY